Management_of_patients_aged_over_60_years_with_supratentorial_glioma:_lessons_from_an_audit._This_audit_of_clinical_management_confirmed_the_poor_prognosis_for_patients_(n_=_80)_aged_over_60_years_with_a_diagnosis_of_supratentorial_glioma._The_median_survival_time_after_diagnosis_was_9_weeks_following_steroids_and_7_weeks_after_biopsy_and_steroids._Cytoreductive_surgery_and_radiotherapy_improved_median_survival_time_by_a_maximum_of_16_weeks,_but_there_was_significant_morbidity_in_some_patients_undergoing_craniotomy._Although_92%_of_the_biopsied_lesions_were_either_glioblastoma_or_anaplastic_astrocytoma,_the_median_survival_of_these_patients_was_similar_to_the_8%_of_patients_confirmed_as_having_intermediate_grade_astrocytoma._Patients_presenting_with_minimal_functional_deficit_(WHO_grade_I_or_II)_had_longer_median_survival_times_than_those_presenting_in_poor_condition_(WHO_grade_III_or_IV)._In_this_series_there_was_no_relationship_between_management_undertaken_and_clinical_status_of_the_patient._The_9%_of_the_cohort_that_survived_1_year_were_treated_in_a_variety_of_ways._This_audit,_together_with_results_from_other_studies,_suggests_that_a_prospective_clinical_trial_of_different_management_regimes_in_elderly_patients_with_supratentorial_gliomas_is_needed._Since_median_survival_time_in_the_most_intensively_treated_patients_will_be_around_6_months,_treatment_evaluation_must_consider_the_quality_of_life_provided.